XML 58 R47.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Long-Term Investments (Details) - Schedule of Long-Term Investment - USD ($) | Jun. 30, 2024 | Dec. 31, 2023
--- | --- | ---
Schedule of Long-Term Investment [Line Items] |  |
Non-marketable Cost Method Investments, net | $ 798,023 | $ 847,252
Equity Method Investments, net | 2,377,549 | 2,527,740
Braingenesis Biotechnology Co., Ltd. [Member] |  |
Schedule of Long-Term Investment [Line Items] |  |
Non-marketable Cost Method Investments, net | 6,794 | 7,213
Genepharm Biotech Corporation [Member] |  |
Schedule of Long-Term Investment [Line Items] |  |
Non-marketable Cost Method Investments, net | 20,742 | 22,021
BioHopeKing Corporation [Member] |  |
Schedule of Long-Term Investment [Line Items] |  |
Non-marketable Cost Method Investments, net | 770,487 | 818,018
ForSeeCon Corporation [Member] |  |
Schedule of Long-Term Investment [Line Items] |  |
Non-marketable Cost Method Investments, net |  |
BioFirst Corporation [Member] |  |
Schedule of Long-Term Investment [Line Items] |  |
Equity Method Investments, net | 1,579,526 | 1,680,488
Rgene Corporation [Member] |  |
Schedule of Long-Term Investment [Line Items] |  |
Equity Method Investments, net |  |

X
- Definition Amount, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and investment in debt security measured at amortized cost (held-to-maturity), classified as noncurrent. + References No definition available. + Details
Name: | us-gaap_DebtSecuritiesNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(12)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_LongTermInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_LongTermPurchaseCommitmentLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvc_BraingenesisBiotechnologyCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvc_GenepharmBiotechCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvc_BioHopeKingCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvc_ForSeeConCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvc_BioFirstCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvc_RgeneCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |